+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Continuous Glucose Monitoring Systems Market (2023-2028) Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • PDF Icon

    Report

  • 174 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5515465

Artificial intelligence (AI) algorithms in combination with continuous monitoring technologies have the potential to revolutionize chronic disease management

The Global Continuous Glucose Monitoring Systems Market is estimated to be USD 5.22 Bn in 2023 and is expected to reach USD 8.04 Bn by 2028 growing at a CAGR of 9.01%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Continuous Glucose Monitoring Systems Market is segmented based on Component, Device Type, Type; Patient Type, Modality, End-Users, and Geography.
  • By Component, the market is classified into Transmitters & Receivers, Sensors, and Insulin Pumps.
  • By Device Type, the market is classified into Continuous Glucose Monitoring (CGM) Systems and Self-Monitoring Blood Glucose (SMBG) Systems.
  • By Type, the market is classified into Non-invasive and Invasive.
  • By Patient Type, the market is classified into Type 1 Diabetes and Type 2 Diabetes.
  • By Modality, the market is classified into Wearable and Non-Wearable.
  • By End-Users, the market is classified into Hospitals & Clinics and Home Care.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Johnson & Johnson, LifeScan Inc., Medtronic PLC, Medtrum Technologies Inc., Menarini Group, Nemaura Medical Inc., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Continuous Glucose Monitoring Systems Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Continuous Glucose Monitoring Systems Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Continuous Glucose Monitoring Systems Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the market are also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Number of Incidence of Diabetic Patients Globally
4.1.2 Growing Regulatory Approvals for the CGM Systems
4.1.3 Growing Adoption Rate of CGM Systems in Home Healthcare
4.2 Restraints
4.2.1 Reimbursement and Stringent Regulatory Concerns
4.3 Opportunities
4.3.1 Technological Advancements and Increased Awareness of CGM Systems
4.3.2 Rising Preferences for Non-invasive Methods and Potential Undiagnosed Patient Population
4.3.3 Increasing Acceptance Rate of In-Home Healthcare
4.4 Challenges
4.4.1 Occurrence of Adverse Effects and Limited Accuracy of CGM Devices
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 SWOT Analysis
5.5 Impact of COVID-19
5.6 Impact of Economic Slowdown & Impending Recession
5.7 Ansoff Matrix Analysis
6 Global Continuous Glucose Monitoring Systems Market, By Component
6.1 Introduction
6.2 Transmitters & Receivers
6.3 Sensors
6.4 Insulin Pumps
7 Global Continuous Glucose Monitoring Systems Market, By Device Type
7.1 Introduction
7.2 Continuous Glucose Monitoring (CGM) System
7.3 Self-Monitoring Blood Glucose (SMBG) System
8 Global Continuous Glucose Monitoring Systems Market, By Type
8.1 Introduction
8.2 Non-invasive
8.3 Invasive
9 Global Continuous Glucose Monitoring Systems Market, By Patient Type
9.1 Introduction
9.2 Type 1 Diabetes
9.3 Type 2 Diabetes
10 Global Continuous Glucose Monitoring Systems Market, By Modality
10.1 Introduction
10.2 Wearable
10.3 Non-Wearable
11 Global Continuous Glucose Monitoring Systems Market, By End-Users
11.1 Introduction
11.2 Hospitals & Clinics
11.3 Homecare
12 Americas' Continuous Glucose Monitoring Systems Market
12.1 Introduction
12.2 Argentina
12.3 Brazil
12.4 Canada
12.5 Chile
12.6 Colombia
12.7 Mexico
12.8 Peru
12.9 United States
12.10 Rest of Americas
13 Europe's Continuous Glucose Monitoring Systems Market
13.1 Introduction
13.2 Austria
13.3 Belgium
13.4 Denmark
13.5 Finland
13.6 France
13.7 Germany
13.8 Italy
13.9 Netherlands
13.10 Norway
13.11 Poland
13.12 Russia
13.13 Spain
13.14 Sweden
13.15 Switzerland
13.16 United Kingdom
13.17 Rest of Europe
14 Middle East and Africa's Continuous Glucose Monitoring Systems Market
14.1 Introduction
14.2 Egypt
14.3 Israel
14.4 Qatar
14.5 Saudi Arabia
14.6 South Africa
14.7 United Arab Emirates
14.8 Rest of MEA
15 APAC's Continuous Glucose Monitoring Systems Market
15.1 Introduction
15.2 Australia
15.3 Bangladesh
15.4 China
15.5 India
15.6 Indonesia
15.7 Japan
15.8 Malaysia
15.9 Philippines
15.10 Singapore
15.11 South Korea
15.12 Sri Lanka
15.13 Thailand
15.14 Taiwan
15.15 Rest of Asia-Pacific
16 Competitive Landscape
16.1 Competitive Quadrant
16.2 Market Share Analysis
16.3 Strategic Initiatives
16.3.1 M&A and Investments
16.3.2 Partnerships and Collaborations
16.3.3 Product Developments and Improvements
17 Company Profiles
17.1 Abbott Laboratories
17.2 AgaMatrix Inc.
17.3 Bayer Ag
17.4 DexCom, Inc.
17.5 F. Hoffmann-La Roche Ltd.
17.6 GlySens Inc.
17.7 Johnson & Johnson
17.8 LifeScan Inc.
17.9 Medtronic PLC
17.10 Medtrum Technologies Inc.
17.11 Menarini Group
17.12 Nemaura Medical Inc.
17.13 Novo Nordisk A/S
17.14 NXP Semiconductors N.V.
17.15 Senseonics Holdings, Inc.
17.16 STMicroelectronics N.V.
17.17 Tandem Diabetes Care, Inc.
17.18 Texas Instruments Inc
17.19 WaveForm Technologies, Inc
17.20 Ypsomed Group
18 Appendix
18.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • AgaMatrix Inc.
  • Bayer Ag
  • DexCom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlySens Inc.
  • Johnson & Johnson
  • LifeScan Inc.
  • Medtronic PLC
  • Medtrum Technologies Inc.
  • Menarini Group
  • Nemaura Medical Inc.
  • Novo Nordisk A/S
  • NXP Semiconductors N.V.
  • Senseonics Holdings, Inc.
  • STMicroelectronics N.V.
  • Tandem Diabetes Care, Inc.
  • Texas Instruments Inc
  • WaveForm Technologies, Inc
  • Ypsomed Group